NCT00056875已完成1 期
Safety and Efficacy of Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 50
- 试验地点
- 2
研究概览
简要总结
This is a single arm dose escalation study of recombinant human keratinocyte growth factor given to patients undergoing allogeneic bone marrow transplantation who are at high risk for graft versus host disease (GVHD).
详细描述
Completion date provided represents the completion date of the grant per OOPD records
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 3 Years 至 65 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
终止
1 期
Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHDAcute Graft Versus Host DiseaseNCT00038792M.D. Anderson Cancer Center7
已完成
1 期
Keratinocyte Growth Factor to Prevent Acute GVHDGraft-vs-Host DiseaseNCT00031148FDA Office of Orphan Products Development72
已完成
早期 1 期
Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced AlopeciaChemotherapy-Induced ChangeAlopeciaHair LossAlopecia DrugsNCT04554732University of Arizona28
已完成
2 期
A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGASmall for Gestational Age InfantNCT03221933Changchun GeneScience Pharmaceutical Co., Ltd.120
已完成
不适用
A study to assess the safety and the effects of using a growth factor, keratinocyte growth factor (KGF), in patients with moderate asthmaRespiratoryAsthmaISRCTN02767559Southampton University Hospitals NHS Trust (UK)20